This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Jalanko, H. Articles by Ruoslahti, E. Search for Related Content PubMed PubMed Citation Articles by Jalanko, H. Articles by Ruoslahti, E.

Differential Expression of -Fetoprotein and -Glutamyltranspeptidase in Chemical and Spontaneous Hepatocarcinogenesis

Division of Immunology, City of Hope National Medical Center, Duarte, California 91010

The expression of two markers of fetal liver, -fetoprotein (AFP) and -glutamyltranspeptidase (GGT), was studied in chemical and spontaneous hepatocarcinogenesis in mice. Serum AFP concentration increased within 3 weeks from the commencement of feeding of o-aminoazotoluene. This early elevation subsided about 3 months after the beginning of the administration of the carcinogen. A new, sustained elevation of the serum AFP level followed at 5 to 6 months accompanied by the appearance of liver tumors. In immunofluorescence, some small oval cells and scattered adult-type hepatocytes contained AFP during the early stage of chemical carcinogenesis. During the later phase, AFP was detected in a few of the nodular areas, in solitary hepatocytes, and in groups of carcinoma cells.

GGT activity in the liver increased within 1 week after the carcinogen regimen was started, preceding the early increase of AFP production. At the final stage, the chemically induced hepatomas contained about 80 times more GGT than did normal liver. In histochemical staining, proliferating oval cells and small areas of hepatocytes stained for GGT during the early weeks, and later most nodules, small areas of nonnodular parenchyma, and carcinomas contained GGT.

During spontaneous carcinogenesis in male C3HeB/FeJ mice, premalignant lesions, accompanied by a slight increase of serum AFP, precede the appearance of liver tumors. No cells staining for AFP were detected during this early stage. Once overt liver cancers had developed, AFP was readily detectable in the tumors and was localized to some but not all carcinoma cells. The corresponding serum AFP levels were highly elevated. In contrast to the high levels of GGT found during chemical carcinogenesis, no elevation of GGT was found in livers at various stages of spontaneous carcinogenesis, including cancers in eight individual mice.

These results indicate that the production of AFP and GGT is not turned on as a single "genetic package," and that these two markers differ in their behavior in liver carcinogenesis.

¹ Recipient of grants from the Orion Foundation, the Lääke Foundation, and the Finnish Cancer Society. To whom requests for reprints should be addressed, at the Department of Bacteriology and Immunology, University of Helsinki, 00290 Helsinki 29, Finland.

² Supported by Grants CA 19894 and CA 16434 from National Cancer Institute, Department of Health, Education, and Welfare.

Received 1/17/79. Accepted 6/ 7/79.